Video & Transcript Research : 'antimicrobial drugs'
Page 1 of 289
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Consumer Protection and Professional Licensure Jun 23rd, 2026
Joint Committee on Consumer Protection and Professional Licensure
Keywords:
animal telehealth, veterinary telemedicine, veterinary telehealth, veterinarian-client-patient relationship, VCPR, animal health, pet care, companion animal, livestock, remote veterinary care, synchronous audio-video, telemedicine, prescription drugs, antimicrobial drugs, controlled substances, xylazine, compounding pharmacy, veterinary practice, Massachusetts Controlled Substances Act, animal owner
Summary:
The Joint Committee on Consumer Protection and Professional Licensure held a hearing on late-filed bills, with testimony heard both in person and remotely. The committee reviewed several measures, including H. 355 and S. 3082 on veterinary telemedicine/telehealth, H. 5445 on additional liquor licenses for East Hampton, and S. 3090/H. 5114 on consumer-connected devices and software support disclosure. The chair outlined hearing logistics, including three-minute testimony limits and written testimony submission, and noted that Lawrence High School students were present to observe.
On the veterinary bills, supporters of H. 355 argued that allowing veterinarians to establish a client-patient relationship remotely would improve access to care for pets whose owners face transportation, mobility, or anxiety-related barriers, and could help veterinarians continue practicing through telemedicine. Opponents of S. 3082, including the Massachusetts Veterinary Medical Association and several veterinarians, said the initial in-person exam is essential to detect conditions that cannot be seen on video, avoid misdiagnosis, and preserve the standard of care; they emphasized that teletriage and follow-up telemedicine are already used after an in-person relationship is established. Committee members pressed both sides on the distinction between teletriage and establishing the relationship, the timing of annual exams, and whether limited exceptions for sedatives or other pre-visit needs might be workable. Senator Lovely testified in support, citing a recent Lyme case where follow-up telemedicine would have been useful.
On H. 5445, Representative Gomez and East Hampton Mayor Salem Derby urged approval of the bill to authorize eight additional liquor licenses, saying the city has reached its current cap, needs economic development, and wants to support downtown revitalization and new restaurant growth. Members asked about public safety and the number of licenses sought; the mayor said local public safety officials support the request and that the licenses would be for restaurants, not bars. On S. 3090 and H. 5114, consumer advocates and cybersecurity experts supported requiring manufacturers of connected devices to disclose software support timelines, arguing it would improve consumer transparency, cybersecurity, and reduce e-waste. Industry groups opposed the bills, saying fixed disclosure requirements could be impractical, create confusion, burden small businesses, conflict with federal efforts, and be difficult to apply to appliances, lighting, and other products with long lifecycles. The committee did not take a substantive vote on the bills during the hearing; at the end, staff announced a forthcoming poll for House members, and the committee voted to adjourn.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Consumer Protection and Professional Licensure Jun 23rd, 2026
Joint Committee on Consumer Protection and Professional Licensure
Keywords:
animal telehealth, veterinary telemedicine, veterinary telehealth, veterinarian-client-patient relationship, VCPR, animal health, pet care, companion animal, livestock, remote veterinary care, synchronous audio-video, telemedicine, prescription drugs, antimicrobial drugs, controlled substances, xylazine, compounding pharmacy, veterinary practice, Massachusetts Controlled Substances Act, animal owner
US
US Federal 2025-2026 Regular Session
Hearings to examine interdicting illicit drug trafficking, focusing on a view from the front lines. Feb 26th, 2025 at 10:00 am
Commerce, Science, and Transportation Committee
Transcript Highlights:
- My 33-year career in policing has focused on violent crime, addressing the impacts of drugs and drug
- This includes the drug cartels that have inundated the United States with deadly drugs, violent criminals
- Certainly at the Office of National Drug Control.
- In some communities, the focus on drug trafficking is often subordinate to others' drug or to other threats
- Stop the drugs from coming.
Keywords:
Coast Guard, maritime drug enforcement, illegal drugs, fentanyl crisis, legislative reforms, public testimony
Summary:
The meeting of the Senate Committee on Commerce, Science, and Transportation addressed critical issues surrounding maritime drug enforcement and the Coast Guard's role in stopping the influx of illegal drugs. The chairman highlighted the alarming consequences of current policies allowing drugs to cross borders, emphasizing the need for legislative reforms, such as the Coast Guard Reauthorization Act of 2025. There was an intense discussion regarding the operational challenges faced by the Coast Guard, which has recently made significant drug seizures, indicating progress but also revealing gaps that need addressing. Several witnesses, including victims of the drug crisis, shared their compelling testimonies, which underscored the urgency for stricter controls and comprehensive support for law enforcement agencies involved in drug interdiction efforts.
NM
New Mexico 2026 Regular Session
Senate - Health and Public Affairs Feb 6th, 2026 at 05:13 pm
Senate Health & Public Affairs
Transcript Highlights:
- And then on page 14, the prescription is written for drugs that may have a cosmetic use.
- talk about severe mental illness and prior authorization there, you're dealing with some very serious drugs
- And we're concerned that by ...removing prior authorization from the drugs that are used for serious
- mental illness, you're making it so that some of these drugs, including opioids, can make it out into
- When, in fact, if there's going to be a change in the drug or the dosage, that's going to be made by
Keywords:
prior authorization, pharmacy benefits manager, PBM, health insurer, prescription drugs, step therapy, formulary, auto-adjudication, electronic portal, appeals, medical necessity, serious mental illness, mental health, schizophrenia, bipolar disorder, major depression, substance use disorder, addiction treatment, cancer, autoimmune disorder
HI
Hawaii 2026 Regular Session
HSH Public Hearing - Thu Feb 5, 2026 @ 9:30 AM HST
Human Services & Homelessness
Transcript Highlights:
- DHS to provide glucagon-like peptide-1 drugs.
- That's the per person for these drugs.
- So they are, it does for any FDA approved indication for the drug.
- Next up we have HB 2456, relating to drugs for weight loss.
- This relating to drugs for weight loss.
Keywords:
disability, communication access, deaf, hard-of-hearing, deaf-blind, healthcare, sign language interpreters, auxiliary aids, weight loss, GLP-1 drugs, obesity, Medicaid, healthcare costs, 910, house, all
Summary:
The committee heard testimony on HP 1972, which would create a nonrefundable family caregiver tax credit, and on a related tax measure to increase the existing dependent care tax credit. Supporters of HP 1972, including AARP, the Executive Office on Aging, the Hawaii Public Health Institute, Hawaii Children’s Action Network, and others, said unpaid caregivers are essential to keeping kūpuna and other loved ones at home and described significant out-of-pocket costs. The Department of Taxation and the Tax Foundation raised technical concerns, including the need to avoid overlap with existing credits and to prevent double-dipping. The department said taxpayers can claim credits to the extent allowed, but recommended explicit language barring the same costs from being claimed under more than one credit. No vote was taken in the excerpt, and the chair moved the bill along after questions.
The committee then heard HP 1975, which would repeal the sunset on the state rent supplement program for kūpuna. AARP, Catholic Charities Hawaii, the Executive Office on Aging, and others supported making the program permanent, saying it helps low-income older adults avoid eviction and homelessness and allows them to remain in affordable housing. Catholic Charities described clients who were paying unsustainable shares of income for rent before receiving the supplement. Members also shared a constituent example of an elderly retiree who needed the subsidy to stay housed. Written support was noted from additional organizations and individuals.
Next, the committee took up HB 1706, which would expand Medicaid prospective payment reimbursement to include mental health services furnished in federally qualified health centers and rural health clinics by mental health professionals under supervision. The Office of Hawaiian Affairs supported the bill, and DHS said it appreciated the intent to address workforce shortages and expand training, but cautioned that unlicensed professionals cannot currently bill Medicaid and that a state plan amendment would be needed, with limited precedent for approval. Members asked about the likelihood and timing of federal approval and whether the bill could help rural areas; DHS said approval is uncertain and the process can take time, though it saw possible alignment with the state’s rural health transformation efforts. The committee also discussed HB 546, a three-year health coverage continuity pilot program for people losing Medicaid coverage. DHS, the Attorney General’s office, DCCA, Catholic Charities, the University of Hawaii, and others testified, with DHS warning that federal changes could increase uninsured rates and that the state may need to act quickly. Catholic Charities and others emphasized the risk to Medicaid recipients, including homeless and near-elderly residents, while DHS explained the state’s existing premium assistance program for certain immigrants and compared it to the proposed pilot. The excerpt ends during discussion of that comparison, with no vote shown.
US
US Federal 2025-2026 Regular Session
Business meeting to consider S.527, to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, S.1040, to amend the Federal Trade Commis Apr 3rd, 2025 at 09:15 am
Senate Judiciary
Transcript Highlights:
- They'll help make prescription drugs more affordable.
- Hopefully, transparency driving down the cost of prescription drugs.
- The fact is drug prices are too high.
- The Drug Competition Enforcement Act would prohibit product hopping.
- drug dealer. manufacturer from offering patients a far more affordable generic version of the drug.
Keywords:
drug competition, product hopping, generic drugs, biosimilars, federal regulations, FTC Act, patent, biological products, healthcare access, affordable prescriptions, Medicare, Federal Trade Commission, sham petitions, competition, public health, unfair competition, healthcare, pharmaceutical, antitrust law, pay-for-delay
Summary:
The meeting focused on addressing the high cost of prescription drugs and the abusive practices that contribute to elevated prices affecting American families. Several bills were presented, including proposals to end pay-for-delay deals and to enhance transparency in the operations of pharmacy benefit managers (PBMs). The discussion was notable for its emphasis on consumer protection and ensuring that cheaper generic drugs reach the market more effectively. Members expressed frustration over past attempts to pass similar legislation stalling in the Senate, leading to renewed efforts to push these bills forward.
OK
Oklahoma 2026 Regular Session
Senate Legislative Session Apr 30th, 2026
Oklahoma Senate Floor Meeting
Transcript Highlights:
- consent to the nomination of Michael Vaughn of Moore to the Oklahoma Board of Licensed Alcohol and Drug
- Michael Vaughn to the Oklahoma Board of Licensed Alcohol and Drug Counselors.
- consent to the nomination of Michael Vaughn of Moore to the Oklahoma Board of Licensed Alcohol and Drug
- consent to the nomination of Michael Vaughan of Moore to the Oklahoma Board of Licensed Alcohol and Drug
Bills:
HB1168
Keywords:
abortion, abortion-inducing drugs, medication abortion, mifepristone, misoprostol, methotrexate, pro-life, pro-choice, reproductive health, unborn child, trafficking, felony, contraception, pharmacist, pharmacy, Title 63, Oklahoma statutes, abortion pill, drug distribution, criminal penalty
Summary:
The Senate first came to order after repeated quorum calls, then devoted a long portion of the meeting to farewell remarks for Senator Darcy Jech. Jech reflected on his 12 years in the chamber, his rural district, campaign experiences, major events during his tenure, and the importance of relationships, compromise, and service. Numerous senators followed with personal tributes, praising his steadiness, humility, faith, work on devotions and the Rural Caucus, and his reputation as a thoughtful, respectful colleague and family man.
After the farewell segment, the Senate moved to executive nominations. The chamber unanimously confirmed Sharon Shell Millington as Director of the Office of Juvenile Affairs, Clayton Bullard as Cabinet Secretary of Health and Mental Health, and Clayton Bullard as administrator of the Oklahoma Health Care Authority. The Senate then approved a slate of Tier 2 nominations, including appointments to the Home Inspector Examiners Committee, the Speech-Language Pathology and Audiology board, the State Fire Marshal Commission, the State Board of Health, the State Board of Licensed Social Workers, the Forensic Review Board, the Oklahoma State Credit Union, the Health Care Workforce Training Commission, the Alarm, Locksmith, and Fire Sprinkler Industry Committee, and the Board of Licensed Alcohol and Drug Counselors.
No debate or opposition was recorded on the nominations, and the votes were overwhelmingly or unanimously in favor. After announcements, the Senate agreed to recess and then adjourned until Monday, May 4 at 1:30 p.m.
NM
New Mexico 2026 Regular Session
House - Health and Human Services Feb 16th, 2026 at 09:04 am
House Health & Human Services
Transcript Highlights:
- So we are now on the committee substitute for SB 20: Prior Authorization and Prescription Drugs.
- for severe mental illness, we're concerned that drugs could be out there that may not be used in an
- We do believe that prior authorization should apply to those drugs.
- How often drugs need to be refilled and prescribed.
- to the chronic maintenance drug is added to the formulary.
Keywords:
SB 101, Health Care Delivery and Access Act, repeal of repeal, sunset repeal, delayed repeal, health care, healthcare, access to care, medical services, provider regulation, state health law, New Mexico, SB 21, Medicare supplement, Medigap, open enrollment, guaranteed issue, birthday month enrollment, health insurance, insurance regulation
NM
New Mexico 2026 Regular Session
Senate - Health and Public Affairs Feb 4th, 2026 at 06:25 pm
Senate Health & Public Affairs
Transcript Highlights:
- So we've gone through different drugs, but one drug in particular harmed them and made them sicker, or
- You're talking about some very serious drugs, and removing prior authorization for those drugs is a concern
- They could be getting some drugs that might cause some different effects that weren't intended to.
- And drug use and random drug testing is a way of life with a lot of the companies. that are trying to
- Inebriated or intoxicated, or you are under the influence of some drug, right? We already have.
Keywords:
prior authorization, pharmacy benefits manager, PBM, health insurer, prescription drugs, step therapy, formulary, auto-adjudication, electronic portal, appeals, medical necessity, serious mental illness, mental health, schizophrenia, bipolar disorder, major depression, substance use disorder, addiction treatment, cancer, autoimmune disorder
OK
Oklahoma 2026 Regular Session
Senate Legislative Session Apr 30th, 2026 at 01:45 pm
Oklahoma Senate Floor Meeting
Transcript Highlights:
- and consent to the nomination of Mi Vaughan of Moore to the Oklahoma board of licensed alcohol and drug
- Mi Vaughan to the Oklahoma Board of Licensed Alcohol and Drug Counselors.
- and consent to the nomination of Mi Vaughan of Moore to the Oklahoma board of licensed alcohol and drug
Bills:
HB1168
Keywords:
abortion, abortion-inducing drugs, medication abortion, mifepristone, misoprostol, methotrexate, pro-life, pro-choice, reproductive health, unborn child, trafficking, felony, contraception, pharmacist, pharmacy, Title 63, Oklahoma statutes, abortion pill, drug distribution, criminal penalty
OK
Oklahoma 2026 Regular Session
Senate Legislative Session Apr 30th, 2026 at 09:00 am
Oklahoma Senate Floor Meeting
Transcript Highlights:
- What if she's trafficking the drugs for herself? Thank you for the question.
- How is this particular drug different from any other illegal drug?
- Or, that a lot of these drugs that are not making it into our state. Follow up.
- And what helped them was not eliminating a drug. What helped them...
- And at the end of the day, these drugs don't give choice.
Bills:
HB1168
Keywords:
abortion, abortion-inducing drugs, medication abortion, mifepristone, misoprostol, methotrexate, pro-life, pro-choice, reproductive health, unborn child, trafficking, felony, contraception, pharmacist, pharmacy, Title 63, Oklahoma statutes, abortion pill, drug distribution, criminal penalty
CA
California 2025-2026 Regular Session
Assembly Environmental Safety and Toxic Materials Committee Mar 25th, 2025
Environmental Safety and Toxic Materials
Transcript Highlights:
- have delayed formal regulatory action on three remaining antimicrobials.
- Containing these three specific antimicrobials, healthcare settings are exempted.
- bland soaps or non-antimicrobial soaps.
- The OTC non-prescription drug section of the Food Drug and Cosmetic Act looks for national uniformity
- the Food Drug and Cosmetic Act.
CA
California 2025-2026 Regular Session
Assembly Environmental Safety and Toxic Materials Committee Mar 25th, 2025
Transcript Highlights:
- or non-antimicrobial soaps. 4.
- And it removes harmful microbes without contributing to antimicrobial resistance.
- The OTC, nonprescription drug section of the Food, Drug, and Cosmetic Act looks for national uniformity
- the Food, Drug, and Cosmetic Act.
- Preempted by the Food, Drug, and Cosmetic Act.
Summary:
The Environmental Safety and Toxic Materials Committee met to adopt its rules, establish quorum, and approve a consent calendar of five bills, all sent to the Committee on Appropriations. The committee then heard three measures: AB 638 by Assembly Member Rodriguez on stormwater capture for irrigation of urban public lands; AB 60 by Assembly Member Papin on banning synthetic nitro musks in cosmetics and personal care products; and AB 916 by Assembly Member Lee on restricting certain antibacterial soap ingredients in consumer hand soaps and body washes.
AB 638 was presented as a climate and water-supply measure directing the State Water Resources Control Board to develop guidelines for capturing and safely reusing stormwater for irrigation. Supporters, including NRDC and several environmental groups, argued it would reduce potable water use and help move stalled projects forward. The bill drew no opposition and received strong support from committee members, including requests to coauthor. It passed the committee on a due pass motion to Appropriations.
AB 60 would ban synthetic nitro musks in cosmetics and personal care products due to health and environmental concerns. Supporters cited endocrine disruption, reproductive harms, persistence in waterways, and international restrictions. The bill passed on a due pass motion to the floor, with one member not voting. AB 916 generated the most debate: supporters said the three targeted antimicrobials offer no added benefit over plain soap, may contribute to health harms and antibiotic resistance, and should be banned in consumer products while exempting health care settings. Opponents argued the ingredients are already under FDA and DTSC review, raised preemption concerns, and warned of costs and impacts on food handling and other uses. After extensive discussion, the committee approved AB 916 on a due pass motion to the Committee on Health, with several no votes.
AZ
Transcript Highlights:
- You develop actually resistance to certain drugs.
- An oral or topical antimicrobial is not the same thing as an IV antimicrobial.
- Many of these drugs require very specific monitoring to ensure safety, including EKGs, drug concentrations
- optimize the use of these very impactful and potentially dangerous drugs.
- Expansion of IV antimicrobial... ...very impactful and potentially dangerous drugs.
Bills:
SB1095, SB1114, SB1116, SB1162, SB1164, SB1178, SB1179, SB1249, SB1253, SB1346, SB1347, SB1446, SB1561, SB1813
Keywords:
gender transition, minors, irreversible surgery, health professionals, puberty-blocking drugs, medical procedures, prohibition, Arizona Revised Statutes, behavioral health, patient brokering, appropriation, state funds, Maricopa County, claims review, medical necessity, American Indian health program, healthcare regulations, healthcare compliance, behavioral health technicians, licensing
AZ
Arizona 2026 Regular Session
03/16/2026 - House Health & Human Services
House Health & Human Services Committee of Reference
Transcript Highlights:
- You develop actually resistance to certain drugs.
- An oral or topical antimicrobial is not the same thing as an IV antimicrobial.
- Many of cardiac toxicity, neurotoxicity, drug interactions, and more.
- Many of these drugs require very specific monitoring to ensure safety, including EKGs, drug concentrations
- Expansion of IV antimicrobial ...IV antimicrobial authority without access to a strong stewardship program
Summary:
The committee heard several bills related largely to Arizona’s behavioral health and Access system, plus a fertility coverage mandate, a state hospital admissions bill, and a naturopathic scope-of-practice bill. SB 1114 would appropriate $1 million to the Maricopa County Attorney’s Office for investigations into behavioral health patient brokering; the sponsor described ongoing fraud involving vulnerable Native American patients, while some members questioned why the Attorney General was not handling the work. The bill passed 10-1 with one present. SB 1116 would require claim denials and appeal determinations for American Indian Health Program behavioral health services to be reviewed by someone with at least two years of relevant clinical experience; Access said it was neutral but raised concerns about vague language and added staffing needs, and the bill passed 7-4 with one present. SB 1346 would require Access to notify providers of claim deficiencies within 72 hours and approve or deny corrected claims within 10 business days; supporters said it would reduce long delays and unpaid claims, while Access said it would need more staff and system changes. The bill passed 7-5.
The committee also approved SB 1347, which requires insurance coverage for fertility preservation services for cancer patients of reproductive age whose treatment is likely to cause infertility, with a religious-employer exemption. Supporters, including cancer survivors and an advocacy representative, said the bill protects patients who must make rapid decisions before treatment begins; insurers were neutral. The bill passed unanimously 12-0. SB 1813 would require the Arizona State Hospital to admit patients based on clinical need rather than county of residence, effectively ending the Maricopa County cap tied to the Arnold v. Sarn settlement. Supporters argued the cap leaves seriously ill patients waiting in other facilities for long periods, while ADHS warned of possible litigation and rural access concerns; the bill passed 9-2 with one present.
Finally, the committee began hearing SB 1178, which would allow naturopathic physicians to administer certain antibiotics, antivirals, and antifungals intravenously. The sponsor argued naturopaths should be able to practice to the full scope of their training amid physician shortages, while the Arizona Medical Association and osteopathic representatives opposed the bill, saying IV antimicrobials are high-risk therapies that require hospital-level training, monitoring, and stewardship. Testimony focused on patient safety, appropriate setting, and whether the bill should be narrowed or amended; no vote on SB 1178 was taken in the portion provided.
AZ
Arizona 2026 Regular Session
02/04/2026 - Senate Regulatory Affairs and Government Efficiency
Regulatory Affairs and Government Efficiency
Transcript Highlights:
- drugs, it sounds like, but there's some drugs that could be harmful or a problem.
- They're under the care of a pill mill that is just trying to sell drugs.
- An oral or topical antimicrobial is not the same as an IV antimicrobial.
- A lot of these drugs require very specific monitoring to ensure safety, including EKGs and drug concentration
- You know, we do prescribe these drugs. They are doctors. They are licensed.
Keywords:
health profession, regulatory boards, criminal activity, notification, auditor general, investigations, veterinary technicians, certification, education alternative, Arizona Revised Statutes, veterinary education, ALTCS, providers, ownership change, healthcare, Arizona Long Term Care System, naturopathic physician, naturopathic medicine, naturopathic doctor, naturopathic physicians medical board
CA
California 2025-2026 Regular Session
Assembly Select Committee On Alternative Protein Innovation Jun 25th, 2025
Transcript Highlights:
- is the number one user of medically important antibiotics, which, when overused, contribute to antimicrobial
- We heard a little bit already about antimicrobial resistance. ...zoonotic disease emergence.
- We heard a little bit already about antimicrobial resistance, or AMR, which compounds the concerns of
- Antimicrobial resistance is already leading to the deaths of millions of individuals around the world
- In addition to that, antimicrobials or antibiotics specifically are often used to stimulate growth in
Summary:
The Select Committee on Alternative Protein Innovation held its first informational hearing to examine the state of alternative protein research, industry growth, and policy needs in California. The chair opened by noting California’s $5 million public investment in UC research in 2022 and framed the hearing around three panels: the climate, environmental, and security potential of alternative proteins; industry scaling and commercialization; and university-led research and workforce development. Members emphasized that the committee will continue with site visits and additional hearings across the state.
The first panel focused on the case for alternative proteins as a climate, land, water, biodiversity, and food-security solution. Shana Fertig of the Good Food Institute argued that plant-based, fermentation-derived, and cultivated proteins can reduce greenhouse gas emissions, land use, and water use while helping California meet its climate and conservation goals. Zane Swanson of CSIS added that alternative proteins could reduce risks tied to zoonotic disease, antimicrobial resistance, supply-chain disruption, and broader national security concerns. In questions, members discussed the role of pharmaceuticals in animal agriculture and how alternative proteins might complement, rather than replace, traditional farming by creating new markets for California crops and helping farmers diversify.
The second panel featured industry leaders Ethan Brown of Beyond Meat, Myra Passick of Upside Foods, and Arye Elfenbein of Wildtype. Brown highlighted plant-based meat’s health and climate benefits, criticized misinformation campaigns against the sector, and urged better labeling, reduced subsidies for factory farming, and more plant-based food in public institutions. Passick described cultivated meat as a scalable food-production technology, said Upside Foods has already produced millions of pounds annually at its Emeryville facility, and asked for grants, low-interest loans, and possible participation in cap-and-trade or similar revenue programs. Elfenbein described cultivated seafood as a way to address overfishing, contamination, traceability problems, and the heavy import dependence of the U.S. seafood supply, while also noting conservation benefits and the need for California to remain a hub for the industry.
The final panel centered on research and workforce development. UCLA’s Amy Rowat described state-funded work on technical bottlenecks such as growing fat cells and creating edible scaffolds, along with a Future Food Fellows program that trains students across science, engineering, law, and policy. UC Santa Cruz economist Galina Hale argued that alternative proteins are necessary to meet future protein demand while reducing food-system emissions, and said California must support the sector through grants, loans, procurement, and research centers to avoid losing leadership to other states and countries. The hearing ended with the chair thanking the witnesses, noting that all materials would be posted online, and saying the committee would continue building policy and budget proposals to support the sector.
MN
Minnesota 2025-2026 Regular Session
House Commerce Finance and Policy Committee 3/10/26
Commerce Finance and Policy
Transcript Highlights:
- Um, and the insurance company says, "I don't know about all that medicine stuff, but this drug will be
- about all that medicine stuff,<00:37:26.200><c> but</c><00:37:26.560><c> this</c><00:37:27.000><c> drug
- </c> stuff, but this drug will be cheaper." stuff, but this drug will be cheaper."
- </c> utilization management for their drug utilization management for their drug formulary,<00:48:30.920
- You know, she has to go through this step protocol, and she knows what drugs work for her.
Keywords:
nudification technology, image rights, privacy protection, sexual exploitation, cybersecurity, recreational camping, utility fees, electricity charges, consumer protection, energy policy, health insurance, insulin, step therapy, diabetes, patient care, prescription drugs, pet shops, animal welfare, dog sales, cat sales
AZ
Transcript Highlights:
- issue by specifying that veterinarian prescriptions based on electronic means for non-tick and flea drugs
- It clarifies that a prescription for antimicrobial drugs based on electronic examination may be issued
- It specifies that the veterinarian may not issue any further antimicrobial drug prescriptions with the
- It allows for a period of three months for veterinarian prescriptions for flea and tick drugs to be initially
- It specifies that the veterinarian may not issue any further antimicrobial drug prescriptions with the
Summary:
The Senate convened with prayer and the Pledge of Allegiance, recognized the doctor of the day and several guests, and then moved through a long floor agenda. Members received House messages, handled committee appointments, and considered a large number of bills in Committee of the Whole, including SB 1046 on information technology, SB 1066 on civil liability and fraudulent scientific research, SB 1332 on light rail expansion participation, and SB 1286 on veterinary prescriptions. Amendments were adopted on each of those measures, with SB 1332 drawing a notable objection from Senator Kuby over state interference in local transit decisions and preference for autonomous vehicles over light rail. SB 1286 was described as a compromise between stakeholders on electronic veterinary prescribing, including limits for antimicrobial drugs and longer windows for flea and tick medications.
The Senate then took up third-reading votes on several bills. SB 1009 on school curriculum passed 16-10 after debate over AED training and whether it created an unfunded mandate. SB 1086 on the Arizona health care cost and payment system passed 18-8. SB 1317, appropriating money to the Attorney General for a coordinated jail reentry program, passed 22-4 amid discussion about the program’s success and concerns over the funding source. SB 1580, SB 1582, SB 1709, SB 1550, and SB 1761 also passed, with comments focusing on school safety funding, probation revocation for dangerous crimes against children, a Queen Creek-related appropriation, and university cooperative extension and experiment station needs. SB 1046 and SB 1286 later passed third reading as well.
The chamber also paused for a St. Patrick’s Day recognition, welcoming Speaker Murphy of the Irish Parliament and reading a proclamation honoring Irish heritage and the Phoenix-Ireland relationship. Afterward, the Senate returned to business, received House requests to return HB 4027 and HB 2444 for reconsideration, heard a personal privilege statement on an ICE detention death, and announced upcoming committee meetings and caucus schedules. The Senate adjourned until Tuesday, March 17, 2026.
TX
Transcript Highlights:
- The human pharmacies do not carry our veterinary specific drugs.
- Go down and buy this drug at the feed store, or I will send you this drug like albendazole."
- Food and Drug Administration, or FDA, on multiple occasions.
- antimicrobials and opioids.
- Our concern is with antimicrobial resistance. We are in violation.
Keywords:
agriculture, finance, young farmers, financial assistance, pest control, veterinarian, veterinary medicine, veterinary telemedicine, telehealth, telemedicine, veterinarian-client-patient relationship, VCPR, animal health, livestock, pets, remote care, electronic means, telephone consultation, controlled substances, prescription drugs
Summary:
The second bill, House Bill 3469, was introduced to address pest control regulations concerning nuisance birds. Representative Campos explained how the bill proposes non-lethal methods to deter these birds, such as the use of laser lights and sounds, which avoids conflict with both state and federal regulations. The committee heard impassioned testimonies from members of the public who shared firsthand experiences regarding the adverse effects of these birds on property and public health. The meeting concluded with both bills being left pending, reflecting a desire for further deliberation among the committee members.